Stromal characteristics are adequate prognosticators for recurrence risk in ductal carcinoma in situ of the breast-Reference-Cited by-同舟云学术

Stromal characteristics are adequate prognosticators for recurrence risk in ductal carcinoma in situ of the breast

Published:2019-04 Issue:4 Volume:45 Page:550-559
ISSN:0748-7983
Container-title:European Journal of Surgical Oncology
language:en
Short-container-title:European Journal of Surgical Oncology

Author:

Van Bockstal Mieke,Lambein Kathleen,Smeets Ann,Slembrouck Laurence,Neven Patrick,Nevelsteen Ines,Weltens Caroline,Van Limbergen Erik,Christiaens Marie-Rose,Van Ongeval Chantal,Wildiers Hans,Libbrecht Louis,Floris Giuseppe

Publisher

Elsevier BV

Subject

Oncology,General Medicine,Surgery

Reference40 articles.

1. Ductal carcinoma in situ - update on risk assessment and management;Pang;Histopathology,2016

2. Identifying progression predictors of breast ductal carcinoma in situ;Yeong;J Clin Pathol,2017

3. Tumor-infiltrating lymphocytes and ductal carcinoma in situ of the breast: friends or foes?;Agahozo;Mod Pathol,2018

4. Risk factors for the development of invasive cancer in unresected ductal carcinoma in situ;Maxwell;Eur J Surg Oncol,2018

5. Continued observation of the natural history of low-grade ductal carcinoma in situ reaffirms proclivity for local recurrence even after more than 30 years of follow-up;Sanders;Mod Pathol,2015

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic prediction value of the clinical-radiomics tumour-stroma ratio in locally advanced rectal cancer;European Journal of Radiology;2024-01

2. Pathological classification of desmoplastic reaction is prognostic factor in cervical adenocarcinoma;Medical Molecular Morphology;2022-07-25

3. Prognostic value of tumor-infiltrating lymphocytes in DCIS: a meta-analysis;BMC Cancer;2022-07-18

4. Image processing improvements afford second-generation handheld optoacoustic imaging of breast cancer patients;Photoacoustics;2022-06

5. Tumor Infiltrating Lymphocytes in Breast Cancer: Implementation of a New Histopathological Biomarker;Biomarkers of the Tumor Microenvironment;2022